| Year |
Citation |
Score |
| 2023 |
Quesnel MJ, Labonté A, Picard C, Zetterberg H, Blennow K, Brinkmalm A, Villeneuve S, Poirier J. Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains. Brain : a Journal of Neurology. PMID 37992295 DOI: 10.1093/brain/awad398 |
0.323 |
|
| 2023 |
Samson AD, Rajagopal S, Pasvanis S, Villeneuve S, McIntosh AR, Rajah MN. Sex differences in longitudinal changes of episodic memory-related brain activity and cognition in cognitively unimpaired older adults with a family history of Alzheimer's disease. Neuroimage. Clinical. 40: 103532. PMID 37931333 DOI: 10.1016/j.nicl.2023.103532 |
0.338 |
|
| 2023 |
Ourry V, Binette AP, St-Onge F, Strikwerda-Brown C, Chagnot A, Poirier J, Breitner J, Arenaza-Urquijo EM, Rabin JS, Buckley R, Gonneaud J, Marchant NL, Villeneuve S. How do modifiable risk factors affect Alzheimer's disease pathology or mitigate its effect on clinical symptom expression? Biological Psychiatry. PMID 37689129 DOI: 10.1016/j.biopsych.2023.09.003 |
0.365 |
|
| 2023 |
St-Onge F, Chapleau M, Breitner JC, Villeneuve S, Binette AP. Tau accumulation and its spatial progression across the Alzheimer's disease spectrum. Medrxiv : the Preprint Server For Health Sciences. PMID 37333413 DOI: 10.1101/2023.06.02.23290880 |
0.422 |
|
| 2023 |
Yakoub Y, Ashton NJ, Strikwerda-Brown C, Montoliu-Gaya L, Karikari TK, Kac PR, Gonzalez-Ortiz F, Gallego-Rudolf J, Meyer PF, St-Onge F, Schöll M, Soucy JP, Breitner JCS, Zetterberg H, Blennow K, ... ... Villeneuve S, et al. Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37294682 DOI: 10.1002/alz.13318 |
0.597 |
|
| 2023 |
Veréb D, Mijalkov M, Chang YW, Canal-Garcia A, Gomez-Ruis E, Maass A, Villeneuve S, Volpe G, Pereira JB. Functional gradients of the medial parietal cortex in a healthy cohort with family history of sporadic Alzheimer's disease. Alzheimer's Research & Therapy. 15: 82. PMID 37076873 DOI: 10.1186/s13195-023-01228-3 |
0.656 |
|
| 2023 |
Wood ME, Xiong LY, Wong YY, Buckley RF, Swardfager W, Masellis M, Lim ASP, Nichols E, Joie R, Casaletto KB, Kumar RG, Dams-O'Connor K, Palta P, George KM, Satizabal CL, ... ... Villeneuve S, et al. Sex differences in associations between APOE ε2 and longitudinal cognitive decline. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36994910 DOI: 10.1002/alz.13036 |
0.356 |
|
| 2023 |
Intzandt B, Sanami S, Huck J, Villeneuve S, Bherer L, Gauthier CJ. Sex-specific relationships between obesity, physical activity, and gray and white matter volume in cognitively unimpaired older adults. Geroscience. PMID 36781598 DOI: 10.1007/s11357-023-00734-4 |
0.455 |
|
| 2022 |
Strikwerda-Brown C, Ozlen H, Pichet Binette A, Chapleau M, Marchant NL, Breitner JCS, Villeneuve S. Trait Mindfulness Is Associated With Less Amyloid, Tau, and Cognitive Decline in Individuals at Risk for Alzheimer's Disease. Biological Psychiatry Global Open Science. 3: 130-138. PMID 36712573 DOI: 10.1016/j.bpsgos.2022.01.001 |
0.74 |
|
| 2022 |
Morrison C, Dadar M, Villeneuve S, Ducharme S, Collins DL. White matter hyperintensity load varies depending on subjective cognitive decline criteria. Geroscience. PMID 36401741 DOI: 10.1007/s11357-022-00684-3 |
0.404 |
|
| 2022 |
Strikwerda-Brown C, Hobbs DA, Gonneaud J, St-Onge F, Binette AP, Ozlen H, Provost K, Soucy JP, Buckley RF, Benzinger TLS, Morris JC, Villemagne VL, Doré V, Sperling RA, Johnson KA, ... ... Villeneuve S, et al. Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment. Jama Neurology. PMID 35907254 DOI: 10.1001/jamaneurol.2022.2379 |
0.431 |
|
| 2022 |
Morrison C, Dadar M, Villeneuve S, Collins DL. White matter lesions may be an early marker for age-related cognitive decline. Neuroimage. Clinical. 35: 103096. PMID 35764028 DOI: 10.1016/j.nicl.2022.103096 |
0.402 |
|
| 2022 |
Groot C, Villeneuve S, Smith R, Hansson O, Ossenkoppele R. Tau PET Imaging in Neurodegenerative Disorders. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 63: 20S-26S. PMID 35649647 DOI: 10.2967/jnumed.121.263196 |
0.384 |
|
| 2022 |
Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ, Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, ... ... Villeneuve S, et al. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. Jama Neurology. PMID 35099509 DOI: 10.1001/jamaneurol.2021.5216 |
0.641 |
|
| 2022 |
Meyer PF, Ashton NJ, Karikari TK, Strikwerda-Brown C, Köbe T, Gonneaud J, Pichet Binette A, Ozlen H, Yakoub Y, Simrén J, Pannee J, Lantero-Rodriguez J, Labonté A, Baker SL, Schöll M, ... ... Villeneuve S, et al. Plasma p-tau231, p-tau181, PET biomarkers and cognitive change in older adults. Annals of Neurology. PMID 35084051 DOI: 10.1002/ana.26308 |
0.639 |
|
| 2021 |
Morrison C, Dadar M, Shafiee N, Villeneuve S, Louis Collins D. Regional brain atrophy and cognitive decline depend on definition of subjective cognitive decline. Neuroimage. Clinical. 33: 102923. PMID 34959049 DOI: 10.1016/j.nicl.2021.102923 |
0.445 |
|
| 2021 |
Janssen O, Jansen WJ, Vos SJB, Boada M, Parnetti L, Gabryelewicz T, Fladby T, Molinuevo JL, Villeneuve S, Hort J, Epelbaum S, Lleó A, Engelborghs S, van der Flier WM, Landau S, et al. Characteristics of subjective cognitive decline associated with amyloid positivity. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34877782 DOI: 10.1002/alz.12512 |
0.632 |
|
| 2021 |
Nilsson NIV, Picard C, Labonté A, Köbe T, Meyer PF, Villeneuve S, Auld D, Poirier J, For The Prevent-Ad Research Group, Alzheimer's Disease Neuroimaging Initiative. Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer's Disease Spectrum. Genes. 12. PMID 34828411 DOI: 10.3390/genes12111805 |
0.354 |
|
| 2021 |
Picard C, Nilsson N, Labonté A, Auld D, Rosa-Neto P, Ashton NJ, Zetterberg H, Blennow K, Breitner JCB, Villeneuve S, Poirier J. Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34590423 DOI: 10.1002/alz.12442 |
0.355 |
|
| 2021 |
Gonneaud J, Baria AT, Pichet Binette A, Gordon BA, Chhatwal JP, Cruchaga C, Jucker M, Levin J, Salloway S, Farlow M, Gauthier S, Benzinger TLS, Morris JC, Bateman RJ, Breitner JCS, ... ... Villeneuve S, et al. Accelerated functional brain aging in pre-clinical familial Alzheimer's disease. Nature Communications. 12: 5346. PMID 34504080 DOI: 10.1038/s41467-021-25492-9 |
0.364 |
|
| 2021 |
Tremblay-Mercier J, Madjar C, Das S, Pichet Binette A, Dyke SOM, Étienne P, Lafaille-Magnan ME, Remz J, Bellec P, Louis Collins D, Natasha Rajah M, Bohbot V, Leoutsakos JM, Iturria-Medina Y, Kat J, ... ... Villeneuve S, et al. Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer's disease. Neuroimage. Clinical. 31: 102733. PMID 34192666 DOI: 10.1016/j.nicl.2021.102733 |
0.336 |
|
| 2021 |
Pichet Binette A, Theaud G, Rheault F, Roy M, Collins DL, Levin J, Mori H, Lee JH, Farlow MR, Schofield P, Chhatwal JP, Masters CL, Benzinger T, Morris J, Bateman R, ... ... Villeneuve S, et al. Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer's disease. Elife. 10. PMID 33983116 DOI: 10.7554/eLife.62929 |
0.374 |
|
| 2021 |
Köbe T, Binette AP, Vogel JW, Meyer PF, Breitner JCS, Poirier J, Villeneuve S. Vascular risk factors are associated with a decline in resting-state functional connectivity in cognitively unimpaired individuals at risk for Alzheimer's disease: Vascular risk factors and functional connectivity changes. Neuroimage. 117832. PMID 33549747 DOI: 10.1016/j.neuroimage.2021.117832 |
0.334 |
|
| 2020 |
Ossenkoppele R, Leuzy A, Cho H, Sudre CH, Strandberg O, Smith R, Palmqvist S, Mattsson-Carlgren N, Olsson T, Jögi J, Stormrud E, Ryu YH, Choi JY, ... ... Villeneuve S, et al. The impact of demographic, clinical, genetic, and imaging variables on tau PET status. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33215319 DOI: 10.1007/s00259-020-05099-w |
0.388 |
|
| 2020 |
Gonneaud J, Bedetti C, Binette AP, Benzinger TLS, Morris JC, Bateman RJ, Poirier J, Breitner JCS, Villeneuve S. Association of education with Aβ burden in preclinicial familial and sporadic Alzheimer disease. Neurology. PMID 32759192 DOI: 10.1212/Wnl.0000000000010314 |
0.404 |
|
| 2020 |
Han JW, Maillard P, Harvey D, Fletcher E, Martinez O, Johnson DK, Olichney JM, Farias ST, Villeneuve S, Jagust W, Mungas D, DeCarli C. Association of vascular brain injury, neurodegeneration, amyloid and cognitive trajectory. Neurology. PMID 32732300 DOI: 10.1212/Wnl.0000000000010531 |
0.643 |
|
| 2020 |
Marchant NL, Lovland LR, Jones R, Pichet Binette A, Gonneaud J, Arenaza-Urquijo EM, Chételat G, Villeneuve S. Repetitive negative thinking is associated with amyloid, tau, and cognitive decline. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32508019 DOI: 10.1002/Alz.12116 |
0.743 |
|
| 2020 |
Pichet Binette A, Vachon-Presseau É, Morris J, Bateman R, Benzinger T, Collins DL, Poirier J, Breitner JCS, Villeneuve S. Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease. Biological Psychiatry. PMID 32228870 DOI: 10.1016/J.Biopsych.2020.01.023 |
0.541 |
|
| 2020 |
Pichet Binette A, Gonneaud J, Vogel JW, La Joie R, Rosa-Neto P, Collins DL, Poirier J, Breitner JCS, Villeneuve S, Vachon-Presseau E. Morphometric network differences in ageing versus Alzheimer's disease dementia. Brain : a Journal of Neurology. 143: 635-649. PMID 32040564 DOI: 10.1093/Brain/Awz414 |
0.474 |
|
| 2020 |
Köbe T, Gonneaud J, Pichet Binette A, Meyer PF, McSweeney M, Rosa-Neto P, Breitner JCS, Poirier J, Villeneuve S. Association of Vascular Risk Factors With β-Amyloid Peptide and Tau Burdens in Cognitively Unimpaired Individuals and Its Interaction With Vascular Medication Use. Jama Network Open. 3: e1920780. PMID 32031648 DOI: 10.1001/jamanetworkopen.2019.20780 |
0.338 |
|
| 2020 |
McSweeney M, Pichet Binette A, Meyer PF, Gonneaud J, Bedetti C, Ozlen H, Labonté A, Rosa-Neto P, Breitner J, Poirier J, Villeneuve S. Intermediate flortaucipir uptake is associated with Aβ-PET and CSF-tau in asymptomatic adults. Neurology. PMID 32015176 DOI: 10.1212/Wnl.0000000000008905 |
0.447 |
|
| 2020 |
Meyer PF, Binette AP, Gonneaud J, Breitner JCS, Villeneuve S. Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography. Jama Neurology. PMID 31961372 DOI: 10.1001/Jamaneurol.2019.4749 |
0.394 |
|
| 2019 |
Villeneuve S. Lifespan Cognitive Reserve-A Secret to Coping With Neurodegenerative Pathology. Jama Neurology. 76: 1145-1146. PMID 31609408 DOI: 10.1001/Jamaneurol.2019.2899 |
0.463 |
|
| 2019 |
Meyer PF, McSweeney M, Gonneaud J, Villeneuve S. AD molecular: PET amyloid imaging across the Alzheimer's disease spectrum: From disease mechanisms to prevention. Progress in Molecular Biology and Translational Science. 165: 63-106. PMID 31481172 DOI: 10.1016/Bs.Pmbts.2019.05.001 |
0.437 |
|
| 2019 |
DeCarli C, Villeneuve S, Maillard P, Harvey D, Singh B, Carmichael O, Fletcher E, Olichney J, Farias S, Jagust W, Reed B, Mungas D. Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury. Journal of Alzheimer's Disease : Jad. PMID 30775991 DOI: 10.3233/Jad-180965 |
0.611 |
|
| 2019 |
Gonneaud J, Baria A, Binette AP, Benzinger TLS, Morris JC, Bateman R, Breitner JCS, Poirier J, Vachon-Presseau E, Villeneuve S. Ic-P-054: Prediction Of Brain Age Using Resting-State Functional Connectivity Reveals Accelerated Aging In The Preclinical Phase Of Autosomal Dominant Alzheimer'S Disease, Irrespectiveof Amyloid Pathology Alzheimers & Dementia. 15: 240. DOI: 10.1016/J.Jalz.2019.06.4897 |
0.385 |
|
| 2019 |
Meyer P, Binette AP, Breitner JCS, Villeneuve S, Initiative ADN. O4-12-04: Cerebrospinal Fluid And Pet Measures Of Tau Pathology Indicate A Different State Of Ad Pathophysiological Progression Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4809 |
0.357 |
|
| 2019 |
Binette AP, Gonneaud J, Villeneuve S, Initiative ADN. Ic-P-174: Flortaucipir Deposition Pattern Across The Alzheimer'S Disease Spectrum: Characterization At The Individual Level Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3957 |
0.335 |
|
| 2019 |
Köbe T, Gonneaud J, Binette AP, Meyer P, McSweeney M, Rosa-Neto P, Breitner JC, Poirier J, Villeneuve S. P1-431: VASCULAR MEDICAL TREATMENTS INFLUENCE THE ASSOCIATION BETWEEN VASCULAR BURDEN AND AMYLOID PATHOLOGY IN ASYMPTOMATIC INDIVIDUALS AT RISK FOR ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P430-P430. DOI: 10.1016/J.Jalz.2019.06.1036 |
0.398 |
|
| 2018 |
Vogel JW, Mattsson N, Iturria-Medina Y, Strandberg OT, Schöll M, Dansereau C, Villeneuve S, van der Flier WM, Scheltens P, Bellec P, Evans AC, Hansson O, Ossenkoppele R. Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease. Human Brain Mapping. PMID 30368979 DOI: 10.1002/Hbm.24401 |
0.648 |
|
| 2018 |
Verfaillie SCJ, Pichet Binette A, Vachon-Presseau E, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JCS, Villeneuve S. Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer's Disease. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 3: 463-472. PMID 29735156 DOI: 10.1016/J.Bpsc.2017.11.012 |
0.503 |
|
| 2018 |
Vogel JW, Vachon-Presseau E, Pichet Binette A, Tam A, Orban P, La Joie R, Savard M, Picard C, Poirier J, Bellec P, Breitner JCS, Villeneuve S. Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease. Brain : a Journal of Neurology. PMID 29688388 DOI: 10.1093/Brain/Awy093 |
0.42 |
|
| 2018 |
Villeneuve S, Vogel JW, Gonneaud J, Pichet Binette A, Rosa-Neto P, Gauthier S, Bateman RJ, Fagan AM, Morris JC, Benzinger TLS, Johnson SC, Breitner JCS, Poirier J. Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease. Jama Neurology. PMID 29482212 DOI: 10.1001/Jamaneurol.2017.5135 |
0.382 |
|
| 2018 |
Binette AP, Vachon-Presseau E, Gonneaud J, Marchant NL, Bellec P, Breitner JCS, Villeneuve S. F5-05-02: Neuropsychiatric Burden Is Related To Increased Amyloid But Not Tau Deposition In Cognitively Normal Older Adults Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2985 |
0.449 |
|
| 2018 |
Gonneaud J, Bedetti C, Binette AP, Benzinger TLS, Morris JC, Bateman RJ, Poirier J, Breitner JCS, Villeneuve S. IC-P-158: GENETIC AND ENVIRONMENTAL FACTORS ARE DIFFERENTIALLY RELATED TO Aβ BURDEN IN THE PRESYMPTOMATIC PHASE OF AUTOSOMAL DOMINANT AND SPORADIC ALZHEIMER'S DISEASE Alzheimers & Dementia. 14: 134. DOI: 10.1016/J.Jalz.2018.06.2225 |
0.347 |
|
| 2018 |
Binette AP, Vachon-Presseau E, Gonneaud J, Marchant NL, Bellec P, Breitner JCS, Villeneuve S. Ic-P-148: Neuropsychiatric Burden Is Related To Increased Amyloid But Not Tau Deposition In Late Middle-Aged Cognitively Normal Individuals With A Family History Of Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2214 |
0.485 |
|
| 2017 |
Mander BA, Zhu AH, Lindquist JR, Villeneuve S, Rao V, Lu B, Saletin JM, Ancoli-Israel S, Jagust W, Walker MP. White matter structure in older adults moderates the benefit of sleep spindles on motor memory consolidation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29084867 DOI: 10.1523/Jneurosci.3033-16.2017 |
0.435 |
|
| 2017 |
Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M. Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load. Neurology. PMID 28062720 DOI: 10.1212/Wnl.0000000000003585 |
0.328 |
|
| 2017 |
Seo SW, Ayakta N, Grinberg LT, Villeneuve S, Lehmann M, Reed B, DeCarli C, Miller BL, Rosen HJ, Boxer AL, O'Neil JP, Jin LW, Seeley WW, Jagust WJ, Rabinovici GD. Regional correlations between [(11)C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort. Neuroimage. Clinical. 13: 130-137. PMID 27981028 DOI: 10.1016/J.Nicl.2016.11.008 |
0.514 |
|
| 2017 |
Vogel JW, Mattsson N, Medina YI, Strandberg O, Schöll M, Dansereau C, Villeneuve S, Flier WMvd, Scheltens P, Bellec P, Evans AC, Hansson O, Ossenkoppele R. Data-Driven Tau-Pet Covariance Networks Enhance Prediction Of Retrospective Cognitive Change In Alzheimer’S Disease Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.687 |
0.646 |
|
| 2017 |
Verfaillie SC, Binette AP, Vachon-Presseau É, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JC, Villeneuve S. [IC-P-037]: SUBJECTIVE COGNITIVE DECLINE IS ASSOCIATED WITH ALTERED POSTERIOR CINGULATE CONNECTIVITY IN ELDERLY WITH A FAMILIAL HISTORY OF ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P33-P34. DOI: 10.1016/j.jalz.2017.06.2309 |
0.359 |
|
| 2017 |
Verfaillie SC, Binette AP, Vachon-Presseau É, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JC, Villeneuve S. [P3-407]: SUBJECTIVE COGNITIVE DECLINE IS ASSOCIATED WITH ALTERED POSTERIOR CINGULATE CONNECTIVITY IN ELDERLY WITH A FAMILIAL HISTORY OF ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P1120-P1121. DOI: 10.1016/J.Jalz.2017.06.1624 |
0.478 |
|
| 2017 |
Binette AP, Vachon-Presseau É, Joie RL, Poirier J, Rosa-Neto P, Collins L, Breitner JCS, Villeneuve S. Moving Away From Single Ad-Signature Roi: Assessing The Relationship Between Whole-Brain Gray Matter Pattern, Ad Pathology, And Cognition In Healthy Elderly At Risk Of Ad Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1579 |
0.496 |
|
| 2016 |
Villeneuve S. Cause of Suspected Non-Alzheimer Disease Pathophysiology: If Not Tau Pathology, Then What? Jama Neurology. PMID 27548079 DOI: 10.1001/Jamaneurol.2016.2842 |
0.399 |
|
| 2016 |
Fletcher E, Villeneuve S, Maillard P, Harvey D, Reed B, Jagust W, DeCarli C. β-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals. Neurobiology of Aging. 40: 173-80. PMID 26973117 DOI: 10.1016/J.Neurobiolaging.2016.01.133 |
0.609 |
|
| 2016 |
Binette AP, Vogel JW, Fonov VS, Madjar C, Tremblay-Mercier J, Breitner JCS, Collins L, Poirier J, Villeneuve S. High Csf Tau Is Related To Reduced Hippocampal Volume And Subjective Cognitive Decline In Healthy Elderly With Amyloid Pathology Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.168 |
0.487 |
|
| 2016 |
Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M. IC-P-008: Multimodal Imaging of Apoe2 Effects in The Aged Brain: Specificity for Reduced Amyloid Pathology Alzheimer's & Dementia. 12: P17-P18. DOI: 10.1016/J.Jalz.2016.06.018 |
0.328 |
|
| 2015 |
Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, La Joie R, Arthur-Bentil SK, Vogel JW, Marks SM, Lehmann M, Rosen HJ, Reed B, Olichney J, Boxer AL, et al. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain : a Journal of Neurology. 138: 2020-33. PMID 25953778 DOI: 10.1093/Brain/Awv112 |
0.496 |
|
| 2015 |
Villeneuve S, Wirth M, La Joie R. Are AD-Typical Regions the Convergence Point of Multiple Pathologies? Frontiers in Aging Neuroscience. 7: 42. PMID 25859215 DOI: 10.3389/Fnagi.2015.00042 |
0.482 |
|
| 2015 |
Villeneuve S, Jagust WJ. Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment. The Journal of Prevention of Alzheimer's Disease. 2: 64-70. PMID 25844350 DOI: 10.14283/jpad.2015.47 |
0.482 |
|
| 2015 |
Villeneuve S, St. Amant H, Vogel JW, Marks S, Wirth M, DeCarli C, Jagust WJ. P3-145: Are low levels of PiB-PET signal clinically significant? Alzheimer's & Dementia. 11: P681-P682. DOI: 10.1016/J.Jalz.2015.06.1013 |
0.341 |
|
| 2015 |
Villeneuve S, Amant HS, Vogel JW, Marks S, Wirth M, DeCarli C, Jagust WJ. IC-01-01: Are low levels of PiB-PET signal clinically significant? Alzheimer's & Dementia. 11: P1-P1. DOI: 10.1016/J.Jalz.2015.06.002 |
0.331 |
|
| 2014 |
Villeneuve S, Brisson D, Marchant NL, Gaudet D. The potential applications of Apolipoprotein E in personalized medicine. Frontiers in Aging Neuroscience. 6: 154. PMID 25071563 DOI: 10.3389/Fnagi.2014.00154 |
0.666 |
|
| 2014 |
Wirth M, Villeneuve S, La Joie R, Marks SM, Jagust WJ. Gene-environment interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8612-7. PMID 24948815 DOI: 10.1523/Jneurosci.4612-13.2014 |
0.64 |
|
| 2014 |
Villeneuve S, Reed BR, Madison CM, Wirth M, Marchant NL, Kriger S, Mack WJ, Sanossian N, DeCarli C, Chui HC, Weiner MW, Jagust WJ. Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions. Neurology. 83: 40-7. PMID 24907234 DOI: 10.1212/Wnl.0000000000000550 |
0.724 |
|
| 2014 |
Wirth M, Haase CM, Villeneuve S, Vogel J, Jagust WJ. Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults. Neurobiology of Aging. 35: 1873-82. PMID 24656834 DOI: 10.1016/J.Neurobiolaging.2014.02.015 |
0.638 |
|
| 2014 |
Villeneuve S, Reed BR, Wirth M, Haase CM, Madison CM, Ayakta N, Mack W, Mungas D, Chui HC, DeCarli C, Weiner MW, Jagust WJ. Cortical thickness mediates the effect of β-amyloid on episodic memory. Neurology. 82: 761-7. PMID 24489134 DOI: 10.1212/Wnl.0000000000000170 |
0.533 |
|
| 2014 |
Reed B, Villeneuve S, Mack W, DeCarli C, Chui HC, Jagust W. Associations between serum cholesterol levels and cerebral amyloidosis. Jama Neurology. 71: 195-200. PMID 24378418 DOI: 10.1001/Jamaneurol.2013.5390 |
0.502 |
|
| 2014 |
Peters F, Villeneuve S, Belleville S. Predicting progression to dementia in elderly subjects with mild cognitive impairment using both cognitive and neuroimaging predictors. Journal of Alzheimer's Disease : Jad. 38: 307-18. PMID 23963293 DOI: 10.3233/Jad-130842 |
0.65 |
|
| 2014 |
Oh H, Madison C, Villeneuve S, Markley C, Jagust WJ. Association of gray matter atrophy with age, β-amyloid, and cognition in aging. Cerebral Cortex (New York, N.Y. : 1991). 24: 1609-18. PMID 23389995 DOI: 10.1093/Cercor/Bht017 |
0.779 |
|
| 2014 |
DeCarli C, Mungas D, Carmichael OT, Villeneuve S, Fletcher E, Singh B, Jagust W, Reed B. P2-075: VASCULAR RISK FACTORS IMPACT COGNITION INDEPENDENT OF PIB PET AND MRI MEASURES OF AD AND VASCULAR BRAIN INJURY Alzheimer's & Dementia. 10: P497-P498. DOI: 10.1016/j.jalz.2014.05.749 |
0.355 |
|
| 2014 |
Rabinovici GD, Cohn-Sheehy BI, Reed B, Villeneuve S, Ghosh PM, Madison C, Lehmann M, Olichney J, DeCarli CS, Miller BL, Borys E, Grinberg LT, Jin L, Seeley WW, Jagust WJ. IC-P-011: COMPARING LIBERAL AND CONSERVATIVE THRESHOLDS FOR AMYLOID PET POSITIVITY IN AUTOPSY-PROVEN CASES Alzheimer's & Dementia. 10: P12-P13. DOI: 10.1016/J.Jalz.2014.05.015 |
0.451 |
|
| 2014 |
Wirth M, Villeneuve S, La Joie R, Marks SM, Jagust WJ. O3-10-02: LIFETIME COGNITIVE ACTIVITY, APOLIPOPROTEIN E GENOTYPE, AND BRAIN BETA-AMYLOID Alzheimer's & Dementia. 10: P228-P228. DOI: 10.1016/J.Jalz.2014.04.324 |
0.533 |
|
| 2014 |
Villeneuve S, Madison C, Ayakta N, La Joie R, Cohn-Sheehy BI, Vogel J, Marks S, Arthur-Bentil SK, Reed B, DeCarli C, Rabinovici GD, Jagust W. IC-02-03: EXISTING THRESHOLDS FOR PIB POSITIVITY ARE TOO HIGH Alzheimer's & Dementia. 10: P4-P5. DOI: 10.1016/J.Jalz.2014.04.026 |
0.385 |
|
| 2014 |
DeCarli C, Mungas D, Carmichael OT, Villeneuve S, Fletcher E, Singh B, Jagust W, Reed B. IC-01-04: VASCULAR RISK FACTORS IMPACT COGNITION INDEPENDENT OF PIB PET AND MRI MEASURES OF AD AND VASCULAR BRAIN INJURY Alzheimer's & Dementia. 10: P2-P3. DOI: 10.1016/J.Jalz.2014.04.021 |
0.57 |
|
| 2013 |
He BJ, Nolte G, Nagata K, Takano D, Yamazaki T, Fujimaki Y, Maeda T, Satoh Y, Heckers S, George MS, Lopes da Silva F, de Munck JC, Van Houdt PJ, Verdaasdonk RM, Ossenblok P, ... ... Villeneuve S, et al. Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013. Clinical Eeg and Neuroscience. PMID 24368763 DOI: 10.1177/1550059413507209 |
0.315 |
|
| 2013 |
Wirth M, Villeneuve S, Haase CM, Madison CM, Oh H, Landau SM, Rabinovici GD, Jagust WJ. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. Jama Neurology. 70: 1512-9. PMID 24166579 DOI: 10.1001/Jamaneurol.2013.4013 |
0.811 |
|
| 2013 |
Chao LL, Decarli C, Kriger S, Truran D, Zhang Y, Laxamana J, Villeneuve S, Jagust WJ, Sanossian N, Mack WJ, Chui HC, Weiner MW. Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI. Plos One. 8: e65175. PMID 23762308 DOI: 10.1371/Journal.Pone.0065175 |
0.531 |
|
| 2013 |
Wirth M, Haase CM, Villeneuve S, Madison C, Oh H, Jagust W. P2-131: Relationships between cognitive activity, Alzheimer's disease pathological biomarkers and cognitive functioning in normal older adults Alzheimer's & Dementia. 9: P393-P394. DOI: 10.1016/J.Jalz.2013.05.775 |
0.769 |
|
| 2013 |
Villeneuve S, Reed B, Madison C, Wirth M, Kriger S, Haase CM, Marchant N, Decarli CS, Chui H, Weiner M, Jagust W. P1-319: The impact of beta-amyloid deposition and vascular risk factors on cortical thickness and cognition Alzheimer's & Dementia. 9: P274-P275. DOI: 10.1016/j.jalz.2013.05.545 |
0.323 |
|
| 2013 |
Villeneuve S, Reed B, Madison C, Wirth M, Kriger S, Haase CM, Marchant N, DeCarli CS, Chui H, Weiner M, Jagust W. IC-P-022: The impact of beta-amyloid deposition and vascular risk factors on cortical thickness and cognition Alzheimer's & Dementia. 9: P21-P22. DOI: 10.1016/J.Jalz.2013.05.023 |
0.545 |
|
| 2013 |
Oh H, Villeneuve S, Madison C, Vogel J, Jagust W. O4-09-05: Association of gray matter atrophy with age, beta-amyloid, white matter hyperintensity and cognition in normal aging Alzheimer's & Dementia. 9: P701-P702. DOI: 10.1016/J.Jalz.2013.04.387 |
0.727 |
|
| 2013 |
Wirth M, Tang G, Villeneuve S, Madison C, Oh H, Jagust W. O1-04-05: High-performing older adults: Cognitive and brain correlates Alzheimer's & Dementia. 9: P134-P134. DOI: 10.1016/J.Jalz.2013.04.071 |
0.529 |
|
| 2012 |
Villeneuve S, Pepin V, Rahayel S, Bertrand JA, de Lorimier M, Rizk A, Desjardins C, Parenteau S, Beaucage F, Joncas S, Monchi O, Gagnon JF. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 142: 1516-23. PMID 23364388 DOI: 10.1378/Chest.11-3035 |
0.442 |
|
| 2012 |
Villeneuve S, Belleville S. The nature of memory failure in mild cognitive impairment: examining association with neurobiological markers and effect of progression. Neurobiology of Aging. 33: 1967-78. PMID 22088679 DOI: 10.1016/J.Neurobiolaging.2011.10.004 |
0.624 |
|
| 2011 |
Villeneuve S, Massoud F, Bocti C, Gauthier S, Belleville S. The nature of episodic memory deficits in MCI with and without vascular burden. Neuropsychologia. 49: 3027-35. PMID 21763333 DOI: 10.1016/J.Neuropsychologia.2011.07.001 |
0.577 |
|
| 2011 |
Hudon C, Villeneuve S, Belleville S. The effect of semantic orientation at encoding on free-recall performance in amnestic mild cognitive impairment and probable Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 33: 631-8. PMID 21644138 DOI: 10.1080/13803395.2010.547663 |
0.636 |
|
| 2011 |
Villeneuve S, Rodrigues-Brazète J, Joncas S, Postuma RB, Latreille V, Gagnon JF. Validity of the Mattis Dementia Rating Scale to detect mild cognitive impairment in Parkinson's disease and REM sleep behavior disorder. Dementia and Geriatric Cognitive Disorders. 31: 210-7. PMID 21474929 DOI: 10.1159/000326212 |
0.389 |
|
| 2011 |
Villeneuve S, Pépin V, Rahayel S, Delorimier M, Bertrand J, Desjardins C, Gagnon J. P1-483: Mild cognitive impairment in chronic obstructive pulmonary disease Alzheimer's & Dementia. 7: S268-S268. DOI: 10.1016/J.Jalz.2011.05.765 |
0.402 |
|
| 2011 |
Villeneuve S, Belleville S. P1-482: The nature of memory failure in mild cognitive impairment: examining effect of progression and comorbid factors Alzheimer's & Dementia. 7: S267-S268. DOI: 10.1016/J.Jalz.2011.05.764 |
0.602 |
|
| 2010 |
Villeneuve S, Belleville S. [Cognitive reserve and neuronal changes associated with aging]. Psychologie & Neuropsychiatrie Du Vieillissement. 8: 133-40. PMID 20525544 DOI: 10.1684/Pnv.2010.0214 |
0.63 |
|
| 2010 |
Belleville S, Villeneuve S, Peters F, Protat S. Fardeau vasculaire, cognition et vieillissement Revue De Neuropsychologie. 2: 106-113. DOI: 10.1684/Nrp.2010.0065 |
0.492 |
|
| 2009 |
Villeneuve S, Belleville S, Massoud F, Bocti C, Gauthier S. Impact of vascular risk factors and diseases on cognition in persons with mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 27: 375-81. PMID 19321941 DOI: 10.1159/000209965 |
0.631 |
|
| 2009 |
Villeneuve S, Belleville S, Lacombe J, Labelle M, Enriquez-Rosas A, Gauthier S. Episodic memory deficits in vascular and non vascular mild cognitive impairment Journal of the Neurological Sciences. 283: 291. DOI: 10.1016/J.Jns.2009.02.196 |
0.588 |
|
| 2006 |
McSweeney M, Binette AP, Meyer P, Gonneaud J, Bedetti C, Ozlen H, Daoust L, Labonte A, Poirier J, Rosa-Neto P, Breitner JC, Villeneuve S. IC-P-209: EARLY INCREASE IN TAU-PET SIGNAL IS ASSOCIATED WITH Aβ BURDEN, CSF P-TAU LEVELS AND COGNITION IN COGNITIVELY NORMAL LATE-MIDDLE-AGED ADULTS Alzheimer's & Dementia. 14: P172-P173. DOI: 10.1016/J.Jalz.2018.06.2276 |
0.405 |
|
| Show low-probability matches. |